dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 29. aprill 2025
Viit
REP-1/2188-1
Registreeritud
29. aprill 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: esmaspäev, 28. aprill 2025 15:21 Adressaat: Signe Leito Teema: Survey: Addition to the work programme (P1 procedure): Citicoline sodium: EDQM-2025-01794-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-01794-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of Citicoline sodium to the work programme of Group 11. In order to have access to the survey, please copy and paste the following link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=257437&lang=en Deadline for replies: 28 May 2025. Thank you. Best regards, On behalf of Aurelie BARTH Andreea Mocoi Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store 1 Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-01794-mail 2
Allikas: Ravimiamet dokumendiregister →